Cargando…
Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin
Despite multimodal treatment approaches, the prognosis of brain metastases (BM) from non-small cell lung cancer (NSCLC) remains poor. Untreated patients with BM have a median survival of about 1 month, with almost all patients dying from neurological causes. We herein present the first report descri...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077992/ https://www.ncbi.nlm.nih.gov/pubmed/26959886 http://dx.doi.org/10.18632/oncotarget.7900 |